Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Samuels group reported 26 HLA class I- and 36 HLA class II-restricted SARS-CoV-2 peptides using infected cells (IHW01070, HEK293T, and Calu-3) and overexpression of SARS-CoV-2 genes in 721.221 B-lymphoblastoid cells with monoallelic HLA expression26.”
From Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes (2024) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 1×
“First, we confirmed that these cells express the ACE2 receptor and transmembrane protease serine 2 (TMPRSS), which are known to be required for SARS-CoV-2 entry into the cells (Hoffmann et al., 2020; Matsuyama et al., 2020; Wan et al., 2020; Zhou et al., 2020; Figure S2B).”
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,406
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656 · cited 7×
“TotestforCD8+Tcellrecognition,weselectedtwoSARS-CoV-2 HLA-I peptides identified in this study that were not previously tested for reactivity and were identified in different samples, We used peripheral blood mononuclear cell (PBMC) samples from 6 COVID-19patientswithdiversediseaseseveritiesandtwohealthy donors (Figure 5…”
InfluentialIngolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887 · cited 1×
“We compiled a map of all the available data of experimentally validated reactive SARS-CoV-2 peptides (Le Bert et al., 2020; Minervina et al., 2020; Nelde et al., 2020; Poran et al., 2020; Schulien et al., 2020; Shomuradova et al., 2020; Snyder et al., 2020; Tarke et al., 2020; Woldemeskel et al.,…”
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Multiple organ infection and the pathogenesis of SARS
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120 · cited 2×
“…individuals, there is no certainty that the antigen tested can actually be presented or that the results are due to cross-reactivity (of peptides that have sequence similarity to other viruses) (Jeyanathan et al., 2020; Mateus et al., 2020) or due to the fact that these are non-self antigens.”
Research works printed but not linked: 66
- Abelin, 2017, Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction, Immunity, 46, 315, 10.1016/j.immuni.2017.02.007 · DOI · Paper page
- Abelin, 2019, Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction, Immunity, 51, 766, 10.1016/j.immuni.2019.08.012 · DOI · Paper page
- Andreatta, 2013, Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach, Bioinformatics, 29, 8, 10.1093/bioinformatics/bts621 · DOI
- Andreatta, 2017, GibbsCluster: unsupervised clustering and alignment of peptide sequences, Nucleic Acids Res., 45, W458, 10.1093/nar/gkx248 · DOI · Paper page
- Bassani-Sternberg, 2017, Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity, PLoS Comput. Biol., 13, e1005725, 10.1371/journal.pcbi.1005725 · DOI · Paper page
- Bilich, 2021, T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals, Sci. Transl. Med., 13, eabf7517, 10.1126/scitranslmed.abf7517 · DOI · Paper page
- Campbell, 2020, Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles, bioRxiv
- Chen, 2020, Pervasive functional translation of noncanonical human open reading frames, Science, 367, 1140, 10.1126/science.aay0262 · DOI · Paper page
- Cheng, 1999, MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens, J. Immunol., 162, 7171, 10.4049/jimmunol.162.12.7171 · DOI
- Cheung, 2007, Induction of T-cell response by a DNA vaccine encoding a novel HLA-A∗0201 severe acute respiratory syndrome coronavirus epitope, Vaccine, 25, 6070, 10.1016/j.vaccine.2007.05.025 · doi:10.1016/j.vaccine.2007.05.025
- Chong, 2020, Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes, Nat. Commun., 11, 1293, 10.1038/s41467-020-14968-9 · DOI · Paper page
- Cox, 2008, MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification, Nat. Biotechnol., 26, 1367, 10.1038/nbt.1511 · DOI · Paper page
- Croft, 2019, Most viral peptides displayed by class I MHC on infected cells are immunogenic, Proc. Natl. Acad. Sci. USA, 116, 3112, 10.1073/pnas.1815239116 · DOI
- Decaro, 2020, Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses, Vet. Microbiol., 244, 108693, 10.1016/j.vetmic.2020.108693 · DOI · Paper page
- Finkel, 2021, SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis, Nature, 594, 240, 10.1038/s41586-021-03610-3 · DOI · Paper page
- Finkel, 2020, The coding capacity of SARS-CoV-2, Nature, 589, 125, 10.1038/s41586-020-2739-1 · DOI · Paper page
- Finkel, 2020, Comprehensive annotations of human herpesvirus 6A and 6B genomes reveal novel and conserved genomic features, eLife, 9, e50960, 10.7554/eLife.50960 · DOI
- Gatto, 2012, MSnbase-an R/Bioconductor package for isobaric tagged mass spectrometry data visualization, processing and quantitation, Bioinformatics, 28, 288, 10.1093/bioinformatics/btr645 · DOI · Paper page
- Gfeller, 2018, The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands, J. Immunol., 201, 3705, 10.4049/jimmunol.1800914 · DOI · Paper page
- Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 · DOI · Paper page
- Hong, 2018, B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen, Immunity, 49, 695, 10.1016/j.immuni.2018.08.012 · DOI · Paper page
- Hoof, 2009, NetMHCpan, a method for MHC class I binding prediction beyond humans, Immunogenetics, 61, 1, 10.1007/s00251-008-0341-z · DOI · Paper page
- Ingolia, 2009, Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling, Science, 324, 218, 10.1126/science.1168978 · DOI · Paper page
- Ingolia, 2014, Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes, Cell Rep., 8, 1365, 10.1016/j.celrep.2014.07.045 · DOI · Paper page
- Jensen, 2018, Improved methods for predicting peptide binding affinity to MHC class II molecules, Immunology, 154, 394, 10.1111/imm.12889 · DOI · Paper page
- Joshi, 2020, Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach, Inform Med Unlocked, 19, 100338, 10.1016/j.imu.2020.100338 · DOI
- Jurtz, 2017, NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data, J. Immunol., 199, 3360, 10.4049/jimmunol.1700893 · DOI · Paper page
- Kalaora, 2016, Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens, Oncotarget, 7, 5110, 10.18632/oncotarget.6960 · DOI · Paper page
- Kalaora, 2018, Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma, Cancer Discov., 8, 1366, 10.1158/2159-8290.CD-17-1418 · DOI
- Kiyotani, 2020, Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2, J. Hum. Genet., 65, 569, 10.1038/s10038-020-0771-5 · DOI · Paper page
- Kloetzel, 2001, Antigen processing by the proteasome, Nat. Rev. Mol. Cell Biol., 2, 179, 10.1038/35056572 · DOI · Paper page
- Lin, 2020, Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2, Virus Res., 288, 198082, 10.1016/j.virusres.2020.198082 · DOI
- Madden, 1993, The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2, Cell, 75, 693, 10.1016/0092-8674(93)90490-H · DOI · Paper page
- Matsuyama, 2020, Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells, Proc. Natl. Acad. Sci. USA, 117, 7001, 10.1073/pnas.2002589117 · DOI · Paper page
- Mi, 2019, Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0), Nat. Protoc., 14, 703, 10.1038/s41596-019-0128-8 · DOI · Paper page
- Minervina, 2020, Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 infection, bioRxiv
- Mulligan, 2021, Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, Nature, 590, E26, 10.1038/s41586-020-03098-3 · doi:10.1038/s41586-020-03098-3
- Nguyen, 2020, Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2, J. Virol., 94, e00510-20, 10.1128/JVI.00510-20 · DOI · Paper page
- Nielsen, 2016, NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets, Genome Med., 8, 33, 10.1186/s13073-016-0288-x · DOI · Paper page
- Nomburg, 2020, Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2, Genome Med., 12, 108, 10.1186/s13073-020-00802-w · DOI · Paper page
- Ohno, 2009, Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A∗0201 transgenic mice, Vaccine, 27, 3912, 10.1016/j.vaccine.2009.04.001 · DOI · Paper page
- Ouspenskaia, 2020, Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer, bioRxiv
- Pontelli, 2020, Infection of human lymphomononuclear cells by SARS-CoV-2, bioRxiv
- Poran, 2020, Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes, Genome Med., 12, 70, 10.1186/s13073-020-00767-w · DOI · Paper page
- Prensner, 2020, Non-canonical open reading frames encode functional proteins essential for cancer cell survival, bioRxiv
- Rodenko, 2006, Generation of peptide-MHC class I complexes through UV-mediated ligand exchange, Nat. Protoc., 1, 1120, 10.1038/nprot.2006.121 · DOI · Paper page
- Sarkizova, 2020, A large peptidome dataset improves HLA class I epitope prediction across most of the human population, Nat. Biotechnol., 38, 199, 10.1038/s41587-019-0322-9 · DOI · Paper page
- Schulien, 2020, Ex vivo detection of SARS-CoV-2-specific CD8+ T cells: rapid induction, prolonged contraction, and formation of functional memory, bioRxiv
- Shomuradova, 2020, SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors, Immunity, 53, 1245, 10.1016/j.immuni.2020.11.004 · DOI · Paper page
- Snyder, 2020, Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels, medRxiv
- Sorem, 2009, Cleavage and secretion of Epstein-Barr virus glycoprotein 42 promote membrane fusion with B lymphocytes, J. Virol., 83, 6664, 10.1128/JVI.00195-09 · DOI
- Starck, 2016, Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance, Immunol. Rev., 272, 8, 10.1111/imr.12434 · DOI
- Stern-Ginossar, 2012, Decoding human cytomegalovirus, Science, 338, 1088, 10.1126/science.1227919 · DOI · Paper page
- Sylvester-Hvid, 2004, SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation, Tissue Antigens, 63, 395, 10.1111/j.0001-2815.2004.00221.x · DOI
- Thomsen, 2012, Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion, Nucleic Acids Res., 40, W281, 10.1093/nar/gks469 · DOI · Paper page
- Tsao, 2006, HLA-A∗0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins, Biochem. Biophys. Res. Commun., 344, 63, 10.1016/j.bbrc.2006.03.152 · DOI
- Tyanova, 2016, The Perseus computational platform for comprehensive analysis of (prote)omics data, Nat. Methods, 13, 731, 10.1038/nmeth.3901 · DOI · Paper page
- Vita, 2019, The Immune Epitope Database (IEDB): 2018 update, Nucleic Acids Res., 47, D339, 10.1093/nar/gky1006 · DOI · Paper page
- Welters, 2003, Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter, Cancer Res., 63, 636
- Wong, 2020, Affinity-Restricted Memory B Cells Dominate Recall Responses to Heterologous Flaviviruses, Immunity, 53, 1078, 10.1016/j.immuni.2020.09.001 · DOI
- Yahalom-Ronen, 2020, A single dose of recombinant VSV-ΔG-spike vaccine provides protection against SARS-CoV-2 challenge, bioRxiv
- Yerly, 2008, Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance, J. Virol., 82, 3147, 10.1128/JVI.02252-07 · DOI
- Zhang, 2020, Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals, Signal Transduct. Target. Ther., 5, 156, 10.1038/s41392-020-00263-y · DOI · Paper page
- Zhao, 2002, Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells, J. Virol., 76, 3007, 10.1128/JVI.76.6.3007-3014.2002 · DOI
- Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 · DOI · Paper page
- Zhu, 2020, A Novel Coronavirus from Patients with Pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 · DOI · Paper page
Cited by
The T cell immune response against SARS-CoV-2
Moss, P. (2022) · Nature Immunology · doi:10.1038/s41590-021-01122-w · Cited by 1,235
Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes
Braun, A., Rowntree, L. C., Huang, Z., Pandey, K., Thuesen, N., Li, C., Petersen, J., Littler, D. R., Raji, S., Nguyen, T. H. O., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51959-6 · Cited by 12
TransHLA: a Hybrid Transformer model for HLA-presented epitope detection
Lu, T., Wang, X., Nie, W., Huo, M., & Li, S. (2025) · GigaScience · doi:10.1093/gigascience/giaf008 · Cited by 10
Metadata
- Authors
- Nagler, A., Kalaora, S., Barbolin, C., Gangaev, A., Ketelaars, S. L. C., Alon, M., Pai, J., Benedek, G., Yahalom-Ronen, Y., Erez, N., Greenberg, P., Yagel, G., Peri, A., Levin, Y., Satpathy, A. T., Bar-Haim, E., Paran, N., Kvistborg, P., & Samuels, Y.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 35
- Issue
- 13
- Pages
- 109305
- ISSN
- 2211-1247
- Cited by
- 52
- References
- 21
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4 d)
- Funders
- Melanoma Research Alliance
- European Research Council
- Israel Science Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.